Skip to main content

Table 1 Expression of BCL9 antigen in different ovarian tissues

From: Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells

Group

n

BCL9

Positive cases

Positive rate %

(−)

(+)

(++)

(+++)

Malignant#

61

11

21

13

16

51

81.97

Borderline**

13

3

3

4

3

10

76.92

Benign*

13

8

4

1

0

5

38.46

Normal

12

12

0

0

0

0

0

  1. *P < 0.05, compared with normal group
  2. **P < 0.01, compared with normal group
  3. #P < 0.01, compared with benign group and normal group